Loading contract…
BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
To provide a comprehensive, end-to-end capillary blood testing service to detect the presence of antibodies generated against SARS-CoV-2 (COVID-19) in the blood. This is the only at-home testing capability not drawing on resource intensive phlebotomy and NHS capacity
| Supplier | Identifier | Award Value | Cross-References |
|---|---|---|---|
| Thriva Limited | 09828160 | £124,400,000 | - |
Government spending data: This supplier has received £70,061,655 in 20 payments (over £25k) from Department of Health and Social Care, UK Health Security Agency (2020-09-17 to 2022-08-17). View full payment history →